Pfizer Inc risk profile
44 Elevated one input has moved against it
Measured 1 September 2026 from PFE's filed statements. Recomputed nightly.
44 (Elevated), driven by Competitive position at 53, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 17 | Contained | Stable | One-year price volatility — 23.9% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 23 | Normal | Stable | Capital spending against operating cash — 0.22x |
| Leverage and coverage | 50 | Elevated | Stable | Net debt to EBITDA — 3.79x |
| Competitive position | 53 | Elevated | Stable | Revenue-growth gap against peers — -61.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.